Sanara Medtech Inc (SMTI) Stock Price, Quote & News

Company Profile

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; F...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 817 529 2300

Website: sanaramedtech.com

Address:

1200 Summit Avenue, Suite 414, Fort Worth, United States

Brugd May. 13 at 1:54 PM

$SMTI *crickets* for chatter but seems to be setup for a squeeze?

0 · Reply

Joby099 May. 13 at 9:21 AM

$BZFD $HTCO $SMTI $BWEN Solid Call!!

0 · Reply

Joby099 May. 12 at 11:59 PM

$BZFD $HTCO $SMTI $BWEN

0 · Reply

Joby099 May. 12 at 6:21 PM

$BZFD $HTCO $SMTI $BWEN

0 · Reply

WallStreetVice May. 12 at 6:15 PM

$SMTI sexy chsrttt

0 · Reply

mimiwor May. 12 at 5:35 PM

$SMTI 13F is coming... Vanguard is qa 10% owner now..

0 · Reply

mimiwor May. 12 at 5:15 PM

$SMTI and 93% gross margin?

0 · Reply

mimiwor May. 12 at 5:12 PM

$SMTI 1.7 P/S with positive net profit... is that a joke?

0 · Reply

mimiwor May. 12 at 5:03 PM

$SMTI If market helped this was already testing out $26 50% range...

0 · Reply

PsychoPass May. 12 at 4:42 PM

$SMTI sold at 23,20$

0 · Reply

Sanara MedTech reports Q1 EPS 4c vs. (7c) last year

May 12, 2026, 8:00 AM EDT - 1 day ago

Sanara MedTech Earnings Call Transcript: Q1 2026

May 11, 2026, 4:50 PM EDT - 2 days ago

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

2026-04-15T12:10:03.000Z - 4 weeks ago

Sanara MedTech initiated with a Buy at Lake Street

Apr 14, 2026, 7:30 AM EDT - 4 weeks ago

Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026

Apr 13, 2026, 9:00 AM EDT - 4 weeks ago

Sanara MedTech, Inc. Investigated by the Portnoy Law Firm

Mar 24, 2026, 8:00 AM EDT - 7 weeks ago

Sanara MedTech Earnings Call Transcript: Q4 2025

Mar 24, 2026, 7:00 AM EDT - 7 weeks ago

Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance

2026-03-11T11:35:38.000Z - 2 months ago

Sanara MedTech announces publication of study on CellerateRX Surgical Powder

Mar 11, 2026, 7:30 AM EDT - 2 months ago

Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds

Mar 3, 2026, 9:10 AM EST - 2 months ago

Sanara MedTech Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 7:30 AM EST - 2 months ago

Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

Feb 17, 2026, 7:30 AM EST - 3 months ago

Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd

2026-01-23T12:35:40.000Z - 3 months ago

Sanara MedTech reports Q4 preliminary net revenue $27.2M-$27.7M

Jan 23, 2026, 7:30 AM EST - 3 months ago

Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

2026-01-07T21:21:10.000Z - 4 months ago

Sanara MedTech receives Biasurge contract from Vizient

Jan 7, 2026, 4:05 PM EST - 4 months ago

Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution

2025-12-10T13:56:15.000Z - 5 months ago

Sanara MedTech, Biomimetic Innovations provide update on OsStic

Dec 10, 2025, 8:37 AM EST - 5 months ago

Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™

Nov 19, 2025, 7:30 AM EST - 6 months ago

Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd

2025-11-14T11:15:33.000Z - 6 months ago

Sanara MedTech price target lowered to $36 from $54 at H.C. Wainwright

Nov 12, 2025, 8:00 AM EST - 6 months ago

Sanara MedTech Earnings Call Transcript: Q3 2025

2025-11-12T12:15:12.000Z - 6 months ago

Sanara MedTech reports Q3 EPS ($3.40) vs (34c) last year

Nov 12, 2025, 7:00 AM EST - 6 months ago

Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited)

2025-11-11T21:21:16.000Z - 6 months ago

Sanara MedTech discontinues Tissue Health Plus business

Nov 11, 2025, 4:05 PM EST - 6 months ago

Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business

Oct 1, 2025, 7:30 AM EDT - 8 months ago

Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025

Sep 3, 2025, 2:45 PM EDT - 9 months ago

Sanara MedTech Transcript: Cantor Global Healthcare Conference 2025

2025-09-02T20:35:34.000Z - 9 months ago

Sanara MedTech CEO Ron Nixon to leave role, Seth Yon to succeed

Sep 2, 2025, 4:30 PM EDT - 9 months ago

Sanara MedTech Inc. Announces Chief Executive Officer Transition

Aug 27, 2025, 4:05 PM EDT - 9 months ago

Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025

2025-08-18T10:20:24.000Z - 9 months ago

Sanara MedTech price target raised to $54 from $53 at H.C. Wainwright

Aug 13, 2025, 8:00 AM EDT - 9 months ago

Sanara MedTech Earnings Call Transcript: Q2 2025

2025-08-13T11:11:29.000Z - 9 months ago

Sanara MedTech reports Q2 EPS (23c) vs (41c) last year

Aug 13, 2025, 7:00 AM EDT - 9 months ago

Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)

Jul 15, 2025, 4:05 PM EDT - 10 months ago

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

Jul 14, 2025, 4:05 PM EDT - 10 months ago

Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program

2025-05-15T10:15:11.000Z - 1 year ago

Sanara MedTech price target raised to $53 from $51 at H.C. Wainwright

May 14, 2025, 8:00 AM EDT - 1 year ago

Sanara MedTech Earnings Call Transcript: Q1 2025

2025-05-14T11:22:10.000Z - 1 year ago

Sanara MedTech reports Q1 EPS (41c) vs. (21c) last year

May 14, 2025, 7:00 AM EDT - 1 year ago

Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

Apr 10, 2025, 4:00 PM EDT - 1 year ago

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

2025-03-26T10:11:10.000Z - 1 year ago

Sanara MedTech price target raised to $51 from $50 at H.C. Wainwright

2025-03-25T18:59:09.000Z - 1 year ago

Sanara MedTech reports Q4 EPS (18c) vs (3c) last year

Mar 25, 2025, 8:00 AM EDT - 1 year ago

Sanara MedTech Earnings Call Transcript: Q4 2024

Mar 25, 2025, 7:00 AM EDT - 1 year ago

Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

Mar 11, 2025, 4:05 PM EDT - 1 year ago

Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

2025-01-24T12:05:33.000Z - 1 year ago

Biomimetic Innovations executes license, distribution agreement with Sanara

Jan 24, 2025, 7:00 AM EST - 1 year ago

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

2025-01-21T21:15:57.000Z - 1 year ago

Sanara MedTech appoints Elizabeth Taylor as CFO

2025-01-21T21:15:17.000Z - 1 year ago

Sanara MedTech enters exclusive license agreement with, investment in Biomimetic

Jan 21, 2025, 4:10 PM EST - 1 year ago

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

Jan 21, 2025, 4:08 PM EST - 1 year ago

Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

Jan 21, 2025, 4:05 PM EST - 1 year ago

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024

Dec 4, 2024, 11:50 AM EST - 1 year ago

Sanara MedTech Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 4:05 PM EST - 1 year ago

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

Nov 13, 2024, 9:00 AM EST - 1 year ago

Sanara MedTech Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:15 PM EST - 1 year ago

Sanara MedTech Inc. Reports Third Quarter 2024 Results

Oct 31, 2024, 9:15 AM EDT - 1 year ago

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

Oct 7, 2024, 9:15 AM EDT - 1 year ago

Sanara MedTech Inc. Announces Changes to Its Board of Directors

Oct 2, 2024, 12:04 PM EDT - 1 year ago

Sanara MedTech Inc (SMTI) Trading 3.79% Higher on Oct 2

Sep 11, 2024, 6:30 AM EDT - 1 year ago

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

Aug 13, 2024, 9:00 AM EDT - 1 year ago

Sanara MedTech Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:15 PM EDT - 1 year ago

Sanara MedTech Inc. Announces Second Quarter 2024 Results

Jul 30, 2024, 9:15 AM EDT - 1 year ago

Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

Jun 12, 2024, 11:00 AM EDT - 2 years ago

Sanara MedTech Transcript: AGM 2024

May 14, 2024, 9:00 AM EDT - 2 years ago

Sanara MedTech Earnings Call Transcript: Q1 2024

May 13, 2024, 9:15 AM EDT - 2 years ago

Sanara MedTech Inc. Announces First Quarter 2024 Results

Apr 29, 2024, 9:15 AM EDT - 2 years ago

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

Apr 18, 2024, 9:15 AM EDT - 2 years ago

Sanara MedTech Inc. Announces $55 Million Debt Facility

Apr 5, 2024, 9:00 AM EDT - 2 years ago

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

Mar 26, 2024, 9:00 AM EDT - 2 years ago

Sanara MedTech Earnings Call Transcript: Q4 2023

Mar 25, 2024, 4:05 PM EDT - 2 years ago

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results

Mar 13, 2024, 9:15 AM EDT - 2 years ago

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates

Feb 22, 2024, 9:15 AM EST - 2 years ago

Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023

Jan 3, 2024, 9:15 AM EST - 2 years ago

Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides

Nov 30, 2023, 9:15 AM EST - 2 years ago

Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing

Nov 14, 2023, 9:00 AM EST - 2 years ago

Sanara MedTech Earnings Call Transcript: Q3 2023

Nov 13, 2023, 4:05 PM EST - 2 years ago

Sanara MedTech Inc. Announces Third Quarter 2023 Results

Oct 10, 2023, 9:15 AM EDT - 2 years ago

Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates

Brugd May. 13 at 1:54 PM

$SMTI *crickets* for chatter but seems to be setup for a squeeze?

0 · Reply

Joby099 May. 13 at 9:21 AM

$BZFD $HTCO $SMTI $BWEN Solid Call!!

0 · Reply

Joby099 May. 12 at 11:59 PM

$BZFD $HTCO $SMTI $BWEN

0 · Reply

Joby099 May. 12 at 6:21 PM

$BZFD $HTCO $SMTI $BWEN

0 · Reply

WallStreetVice May. 12 at 6:15 PM

$SMTI sexy chsrttt

0 · Reply

mimiwor May. 12 at 5:35 PM

$SMTI 13F is coming... Vanguard is qa 10% owner now..

0 · Reply

mimiwor May. 12 at 5:15 PM

$SMTI and 93% gross margin?

0 · Reply

mimiwor May. 12 at 5:12 PM

$SMTI 1.7 P/S with positive net profit... is that a joke?

0 · Reply

mimiwor May. 12 at 5:03 PM

$SMTI If market helped this was already testing out $26 50% range...

0 · Reply

PsychoPass May. 12 at 4:42 PM

$SMTI sold at 23,20$

0 · Reply

mimiwor May. 12 at 3:56 PM

$SMTI Just letting you know, they are expected to generate about $120 million in revenue this year based on guidance, while the current market cap is only around $200 million, and the company just turned net profitable. This is usually when a stock starts getting more expensive.

0 · Reply

mimiwor May. 12 at 3:44 PM

$SMTI there is a gap and fundamental...Market maker will play this thing imo

0 · Reply

mimiwor May. 12 at 3:27 PM

$SMTI tiny float.. turned net positive..12x EV;;

0 · Reply

Joby099 May. 12 at 2:32 PM

$BZFD $HTCO $SMTI $BWEN Great call! That’s probably why his Discord been so consistent 🔥 https://www.youtube.com/watch?v=gG3p4nUB6Cw

0 · Reply

NeedToQuitMyJob May. 12 at 2:44 AM

$SMTI Didn't they report one day early compared to what they said on their IR website?

0 · Reply

focafoca99 May. 12 at 2:25 AM

$SMTI released its Q1 2026 financial results for the quarter ended March 31, 2026.

0 · Reply

topstockalerts May. 12 at 2:01 AM

After Hours Top Gainers PT2 $QUBT $BOT $HTCO $HLIT $SMTI

0 · Reply

topstockalerts May. 11 at 11:31 PM

After Hours Top Gainers PT2 $QUBT $HLIT $PACS $HTCO $SMTI

0 · Reply

StocktwitsEarnings May. 11 at 9:30 PM

$SMTI Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.05 up 112.20% YoY • Reported revenue of $27.8M up 18.62% YoY • Sanara expects full year 2026 net revenue to range from $116M to $121M, representing growth of approximately 13% to 17% compared to $103.1M for full year 2025.

0 · Reply

PsychoPass May. 11 at 3:42 PM

$SMTI started at 17.90

0 · Reply

PsychoPass Apr. 15 at 3:53 PM

$SMTI soldi at 20.2$

1 · Reply

StocktwitsEarnings Mar. 24 at 11:18 AM

$SMTI Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.19 down -5.56% YoY • Reported revenue of $27.55M up 4.72% YoY • Sanara MedTech Inc. reaffirmed its full year 2026 net revenue guidance, expecting $116 million to $121 million, representing approximately 13% to 17% growth compared to full year 2025.

0 · Reply

Market Cap	165.15M
Revenue (ttm)	103.12M
Net Income (ttm)	-37.56M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	115.00
Profit Margin	-36.42%
Debt to Equity Ratio	7.75

Volume	119,500
Avg Vol	60,650
Day's Range	N/A - N/A
Shares Out	9.17M
Stochastic %K	41%
Beta	1.16
Analysts	Strong Sell
Price Target	$34.00